Pneumocystis carinii is the most common cause oflife-threatening pneumonia in immunocompromised patients. In the current study, surfactant protein A (SP-A), the major nonserum protein constituent of pulmonary surfactant, is demonstrated to bind P. carinii in a specific and saturable manner. SP-A is surface bound and does not appear to be internalized or degraded by the P. carini organism. Furthermore, SP-A binding to P. carini' is time-and calcium-dependent and is competitively inhibited by mannosyl albumin. In the absence of calcium or the presence of excess mannosyl albumin, SP-A binding to P. carinii is reduced by 95 and 71%, respectively. SP-A avidly binds P. carinil with a Kd of8 x 10-9 M and an estimated 8.4 X 106 SP-A binding sites per P. carinii organism, as determined from Scatchard plots. SP-A is shown to bind P. carinli in vivo, and a putative binding site for SP-A on P. carini is demonstrated to be the mannoserich surface membrane glycoprotein gpl20. These findings suggest that P. carinii can interact with the phospholipid-rich material in the alveolar spaces by specifically binding a major protein constituent of pulmonary surfactant. (J. Clin. Invest.
Introduction
The most characteristic morphologic finding in Pneumocystis carini pneumonia is the filling ofthe alveoli with an abundant network of foamy surfactant-like material that encases the P. carinii organisms (1) (2) (3) . The accumulation of this lipid-and protein-rich material in the alveolar spaces likely contributes to the impairment ofgas exchange observed in P. carinii pneumonia (4) . However, the interaction of P. carini with the components of pulmonary surfactant is poorly understood.
Surfactant protein A (SP-A),' a surfactant-associated protein (5) , may play a role in surfactant organization and homeostasis. SP-A has been implicated in the adsorption of phospholipid to the alveolar air-liquid interface (6) , the in vitro regula-tion of surfactant secretion (7) (8) (9) and the in vitro uptake of phospholipid by alveolar type II cells (10) . In addition, SP-A is recognized as a calcium-dependent lectin with a binding specificity for immobilized mannose, fucose, glucose, and galactose (11) .
The predominant surface membrane protein on P. carinji is a glycoprotein with an estimated molecular mass of 1 kD, known as P. carinli gpl 20 (12) . Recent studies suggest that gp120 may serve to mediate attachment of P. carinli to the alveolar epithelium (13) . P. carinli gpl 20 is heavily glycosylated with mannose-containing oligosaccharide chains (14) that could function as ligands for SP-A.
In this study, SP-A is demonstrated to avidly bind P. carinii both in vitro and in vivo. This binding is saturable, calcium dependent, and carbohydrate specific. Ligand immunoblotting of size-fractionated P. carinli membrane proteins demonstrate that SP-A selectively binds the carbohydrate expressed by the mannose-rich gp 120. Finally, SP-A binding to P. carinil in vivo is verified by immunoblot analysis of P. carinli obtained by lung lavage using polyclonal antibody to rat SP-A.
Methods
Isolation ofP. carinji. P. carinli pneumonia was induced in pathogenfree rats by immunosuppression with dexamethasone and transtracheal inoculation of P. carinli organisms as described by Bartlett et al. (15) . P. carinji organisms were then harvested by lung lavage as previously described (16, 17) . P. carinji were purified from the lavage fluid by a method adapted from Masur and Jones (18) . The lavage fluid was centrifuged (600 g for 10 min) to pellet inflammatory and alveolar cells, and the supernatant was saved. The cell pellet was resuspended and cytopreparation smears were made using a cytologic centrifuge (Cytospin II; Shandon Southern Instruments Inc., Sewickley, PA). The cytopreparation smears were stained with Gomori methenamine silver stain (19) and Diff-Quick (Difco Laboratories, Inc., Detroit, MI) stain (20) to confirm the presence of P. carinji organisms. Any suspensions found to contain bacterial, fungal, or inflammatory cell contamination were discarded. The supernatant was centrifuged (2,000 g for 30 min) and the resulting P. carinji pellet was resuspended in HBSS without calcium or magnesium (Gibco Laboratories, Grand Island, NY) plus 0.6 mM EDTA. Examination of this suspension by light microscopy demonstrated P. carinii trophozoites to represent 97-98% of the intact cellular material present. P. carinii trophozoites were quantified by the method of Bartlett et al. (21) .
SP-A isolation, purification, and iodination. Surfactant protein A was purified by previously described methods (22) . Briefly, surfactant was obtained by lung lavage of rats 4 wk after intratracheal instillation of silica in saline. The surfactant was purified as described by Hawgood et al. (6) and delipidated by extraction with 1-butanol. The butanol-insoluble protein precipitate was separated from the lipids by centrifugation (2,000 g for 30 min). The protein was suspended in 5 mM Tris/ column of mannose-Sepharose 6B (23) . The SP-A bound to the column in the presence of2 mM CaCl2 was then eluted with 2 mM EDTA. The eluate was further purified and residual EDTA removed by gel filtration over a Bio-Gel A 5-m column (Bio-Rad Laboratories, Richmond, CA). Protein content was estimated using the method ofLowry et al. (24) .
'251-SP-A was prepared as previously described according to the method of Bolton and Hunter (25) . Rat SP-A (1-2 mg) was dialyzed at 4VC against a 0.1 M sodium borate buffer (pH 8.5). A 1-1.5-ml aliquot of the SP-A suspension was added directly to an iced Bolton-Hunter Reagent vial (Amersham Corp., Arlington Heights, IL) after the benzene was removed by evaporation under a stream of nitrogen. The reaction mixture was incubated for 30 min on ice with occasional mixing. Free '25I was removed by dialysis against a 5-mM Tris buffer (pH 7.4). The specific activity of the '25I-SP-A was 31-54 MCi/mg protein.
The purity of the SP-A and '25I-SP-A obtained by these methods has previously been demonstrated (22) .
Binding ofI'25-SP-A to P. carinii. Isolated P. carinii were incubated 18 h in DME (Whittaker MA Bioproducts, Walkersville, MD) supplemented with 0.6 mg/ml glutamine, 100 U/ml penicillin, 100 ,g/ml streptomycin, 0.5 jg/ml amphotericin B, 4 Mg/ml gentamicin, 1% BSA, and 5 mM EGTA (pH 7.4). To prepare P. carinii for binding experiments, the P. carinii suspension was centrifuged (2,000 g for 15 min), the supernatant was discarded, and the pellet was washed once with HBSS containing 2 mM CaCl2 supplemented with 1% BSA (HBSS+) and finally resuspended in DME plus 1% BSA to a concentration of 5 X 105 P. carinii organisms/ml. Binding of SP-A to P. carinii trophozoites was quantified using a modification of the method of Proctor et al. (26) . Binding assays performed to determine the specific binding of SP-A to P. carinii contained 5 X 104 P. carinii (100 Ml), 60-1,500 ng '251I-SP-A (I10-30 Ml) in sample buffer (5 mM Tris/HCl and 1% BSA, pH 7.4) in the presence and absence of 10 Mg unlabeled SP-A. The reaction suspension was incubated for 30 min in an atmosphere of 90% air and 10% CO2 at 37°C. The suspension was spun in a microfuge (13, The ability of anti-SP-A IgG to inhibit binding was also examined in a similar manner using 0, 1.0, and 2.5 Mg of antibody. Polyclonal rabbit anti-rat SP-A IgG was raised in New Zealand white rabbits. The animals were injected with 50-100 Mg of purified rat SP-A in Freund's complete adjuvant. A second booster injection of 50-100 Mg of rat SP-A in Freund's incomplete adjuvant was given at 14 d. The titer of antibody was assayed 10 d after the booster injection by ELISA using purified rat SP-A as the solid phase. A repeat booster injection was given in cases where the titer was < 1:10,000. Antibody was isolated from immune rabbit serum on Protein-A Sepharose CL-4B (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ) and eluted with 0.1 M acetic acid. The eluted fraction was neutralized immediately in Tris buffer and adsorbed against rat serum bound to Affigel-IO and Affigel- 15 columns (Bio-Rad Laboratories). The antibody was exhaustively dialyzed against PBS and stored at -20°C. The purity and specificity of this antibody has previously been demonstrated (9) .
To examine whether SP-A is surface bound or internalized, binding assays were performed as above at 37°and at 4°C, a temperature at which internalization is inhibited. A second method to determine whether 1251I-SP-A was surface bound used release of '25I-SP-A from P.
cariniiby washing the cells with 5 mM Tris/HCl plus 5 mM EGTA (pH 7.4). Since the binding of SP-A to P. carinji is calcium dependent, this treatment releases surface-bound but not internalized '251-SP-A.
Finally, autoradiography and TCA precipitation of purified and bound '251-SP-A were used to study whether bound SP-A remains intact or is degraded after binding. P. carinji bound by '251-SP-A were solubilized in SDS-PAGE sample buffer (0.125 M Tris, 20% glycerol, 4% SDS, 0.002% bromophenol blue, and 4% 2-mercaptoethanol), and the proteins were size fractionated by SDS-PAGE. The gel was dried and exposed to Kodak X-Omat RP film for 2 h at -70'C. TCA precipitation of purified and P. carinii-bound '251-SP-A was done using a TCA final concentration of 26%.
Binding of SP-A to P. carinii membrane proteins. Rat P. carinii organisms obtained from culture (27) were solubilized in 9.5 M urea, 2% (wt/vol) NP-40, 2% ampholines (composed of 1.6% pH range 5-7 and 0.4% pH range 3-10) and 5% 2-mercaptoethanol. The P. carinli proteins were then electrofocused and size fractionated by two-dimensional gel chromatography as described by O'Farrell (28) . To demonstrate whether SP-A binds a P. carinii surface protein, the protein in the two-dimensional gel was electrophoretically transferred for 30 min to an Immobilon-P PVDF transfer membrane (Millipore Corp., Bedford, MA) using Towbin buffer (29) supplemented with 0.05% SDS. The membrane was blocked with 3% BSA, 5 mM Tris, 2 mM CaCl2, 0.5% Triton X-100 pH 7.4 (buffer A) for 2 h. The membrane was blotted with 20 MLg/ml SP-A in buffer A for 2 h at room temperature. After this, all washes and incubations were done at 4VC. After each incubation the membrane was washed five times, 5 min/wash with buffer A. The membrane was immunoblotted with 20 Mg/ml polyclonal rabbit antibody to rat SP-A for 2 h. The bound SP-A was visualized using horseradish peroxidase-conjugated goat anti-rabbit IgG antibody developed with 4-chloro-I -naphthol in diethylene glycol (Bio-Rad Laboratories).
Demonstration ofin vivo binding ofSP-A to P. carinii. To demonstrate whether SP-A is bound to P. carinii organisms in vivo, organisms were collected as before in lavage fluid containing 2 mM CaCl2. Lung lavage from uninfected animals was obtained and purified in a similar fashion and used as a control. The P. carinii obtained from lung lavage were centrifuged (71,000 g for 90 min) through a 20-60% discontinuous sucrose density gradient. The cell band present at the 20-30% (0.58-0.88 M) sucrose interface was collected and solubilized in SDS-PAGE sample buffer. The P. carinii and the corresponding control fractions were subjected to SDS-PAGE, transferred to nitrocellulose, and then immunoblotted with rabbit polyclonal antibody to rat SP-A. The presence ofSP-A was identified using horseradish peroxidase-conjugated goat anti-rabbit IgG antibody directed against the rabbit polyclonal anti-SP-A antibody.
Statistical analysis. Values are expressed as means±SEM. Differences between control and experimental data groups were compared using the one-tailed t test or ANOVA with paired comparisons performed using Fisher's LSD method. Statistical significance was accepted for P < 0.01.
Results
'25I-SP-A binding to P. carinii trophozoites. SP-A binds P. carinii in vitro in a time-dependent manner and achieves apparent equilibrium by 30 min (Fig. 1 The calcium requirement for optimal binding ofSP-A to P. carinii was examined by repeating the SP-A binding assays in the presence of increasing concentrations of extracellular calcium (Fig. 2) . In the absence of calcium only 2.85±0.27 ng of 1251-SP-A is bound, whereas in the presence of 2 mM calcium Binding assays were performed using 1 X 106 P. carinii incubated with 100 ng '251-SP-A in HBSS, 2 (Fig. 3 A) . (33) (Fig. 4 A) (Fig. 4 B) . were performed as in Fig. 1 To determine whether SP-A recognized carbohydrates expressed by P. carinii surface membrane glycoproteins, 251I-SP-A binding experiments were conducted in the presence and absence of excess carbohydrate. Because P. carinii expresses high mannose-type oligosaccharides on its surface ( 14) and the specificity ofSP-A for mannose has been well described (1 1), a-methyl-D-mannopyranoside and mannosyl-BSA were used to determine whether SP-A binding to P. carinii exhibited a specificity for carbohydrate. Mannosyl-BSA effectively inhibits 1251-SP-A binding to P. carinli (Fig. 6 A) . SP-A binding can be inhibited by 71% in the presence of 2.42 mM mannose when mannose is presented as the multivalent glycoprotein mannosyl-BSA, whereas the monosaccharide a-methyl-D> mannopyranoside (Fig. 6 B) requires concentrations as high as 500 mM to achieve a similar degree of inhibition (73%). Other monosaccharides known to be ligands for SP-A, such as N-acetyl-D-glucosamine also inhibit SP-A binding to P. carinii at high concentrations (data not shown). However, there is a limitation to the use ofmonosaccharides in studying SP-A binding, because the carbohydrate specificity of SP-A decreases as the monosaccharide concentration increases. The ability of low mannose concentrations, in the form of mannosyl-BSA, to inhibit binding of SP-A to P. carinii suggests that a glycoprotein expressed by P. carinii is a possible ligand for SP-A.
SP-A binding to P. carinii membrane proteins. To demonstrate the SP-A target binding site on P. carinii, SP-A binding to P. carinii membrane proteins was examined by ligand immunoblot analysis. Whole P. carinii proteins were resolved by two-dimensional gel chromatography and stained with Coomassie brilliant blue R-250 (Fig. 7 A) . Two-dimensional chromatography of P. carinii proteins reveal a 116-120-kD basic protein, representing the majority of P. carinli surface protein (12) known as gpl20.
The immunoreactivity for SP-A present on the ligand immunoblot analysis (Fig. 7 B) demonstrates that SP-A binds the P. carini 120-kD surface glycoprotein, as well as a smaller protein with an estimated mass of 80 kD. There is no immunoreactivity for SP-A present when immunoblots are performed with omission of the initial SP-A incubation (data not shown). Ligand immunoblots of P. carinii gpl20 treated with 50 mM sodium metaperiodate (34), express no immunoreactivity for SP-A (data not shown), demonstrating that oxidation of the carbohydrate residues of gpl2O destroys the epitope required for SP-A binding. The inhibition of SP-A binding to whole P. carinii organisms with mannosyl-BSA and the periodate sensi- acid structure of SP-A reveals that the protein has several discrete structural domains (37) (38) (39) (40) (41) . Of particular relevance to this study are the amphipathic helix and hydrophobic region, which form a putative phospholipid-binding domain (42) , and the globular carboxyl terminus region, which contains a carbohydrate-binding domain (43) . The amino acid sequence of the carbohydrate recognition domain shows sequence homology with the carbohydrate-recognition domains of other C-type lectins, specifically the soluble serum lectin, mannose-binding protein, and the hepatic and macrophage mannose receptor (43) (44) (45) . SP-A has previously been shown to require calcium for binding to immobilized saccharides or to its receptor on isolated alveolar type II cells (22, 46, 47) . These data suggest that SP-A binding to P. carinii is also a carbohydrate-dependent and calcium-requiring process. The multiple affinities of SP-A for carbohydrate and phospholipid (42, 48) may enable this protein to simultaneously bind P. carini and the phospholipid components of surfactant. Therefore, SP-A may facilitate the accumulation of surfactant phospholipids about the organism. Saturation of P. carinii's major antigenic determinant, gp120, by SP-A alone or in combination with adsorbed surfactant may alter the structure of this immunodeterminant such that recognition by host immune surveillance cells could be avoided. Parasite acquisition of host molecules is a recognized means of host immune response avoidance (49) . The interaction of P. carinii with SP-A could potentially result in the combined disruption of SP-A's regulatory role of alveolar phospholipid homeostasis and the disorganization of the alveolar phospholipid monolayer, in part explaining the alveolar filling process and hypoxia seen in P. carinii pneumonia (4) .
The predominant antigenic determinant on the P. carinii cell membrane is the mannose-rich membrane glycoprotein gpl20 (34, 50) . In this study, SP-A is demonstrated to bind P. carinji gp120, supporting the hypothesis that gp120 is a putative binding site on P. carinii for SP-A. The ability of mannosyl-BSA to inhibit binding of SP-A to gpl20 and the periodate sensitivity of SP-A binding suggests that the SP-A binding is dependent on intact oligosaccharides present on the gpl20 ligand. Furthermore, immunoblot analysis of isolated P. carini membrane proteins demonstrates the presence of SP-A, indicating that SP-A is adherent to P. carini in vivo.
P. carinji gpl20 has been demonstrated to play a potential role in the mechanism of adherence of the organism to the alveolar epithelium (13) . The binding ofthe carbohydrate recognition domain of SP-A to P. carini in the alveolar lining fluid may provide the organism access to the alveolar epithelium via fibronectin-mediated attachment between SP-A's free collagen-like domain and the alveolar epithelium. This is suggested by fibronectin's ability to bind the collagenous domain of the structurally homologous protein complement Clq (51) and fibronectin's ability to mediate attachment ofP. carinji to the alveolar epithelium (15) .
In summary, this study provides direct evidence that SP-A, the major protein constituent of surfactant, binds P. carinii. This binding is specific and saturable, time dependent, carbohydrate specific, and calcium requiring. The binding site on the P. carindi organism appears to be the mannose-rich membrane glycoprotein gp 120. The binding of SP-A to P. carini in vivo may enhance adsorption of surfactant to the organism, possibly impede host defenses against P. carinii, as well as potentiate P. carini adherence to the alveolar epithelium.
